A single mitochondrial DNA deletion accurately detects significant prostate cancer in men in the PSA 'grey zone'.

Specific PHGKB|Cancer|PHGKB

Prostate Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Dec 21, 2017

---

• A single mitochondrial DNA deletion accurately detects significant prostate cancer in men in the PSA 'grey zone'.  
  Creed Jennifer et al. World journal of urology 2017 Dec
• Germline BRCA mutation in male carriers-ripe for precision oncology?  
  Leão Ricardo Romão Nazário et al. Prostate cancer and prostatic diseases 2017 Dec
• Recommendations for genetic counseling and genetic testing for hereditary prostate cancer  
  Medical Xpress, Dec 13, 2017
• Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017  
  VN Giri et al, J Clin Onc, Dec 13, 2017
• Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.  
  Giri Veda N et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Dec JCO2017741173
• Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.  
  Spratt Daniel E et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Nov JCO2017742940
• Clinical Utility of CLIA-Grade AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer.  
  Markowski Mark C et al. JCO precision oncology 2017 2017
• Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer.  
  Flores-Morales Amilcar et al. Frontiers in oncology 2017 7267
• Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.  
  Hovelson Daniel H et al. Oncotarget 2017 Oct 8(52) 89848-89866
• Utility of single cell genomics in diagnostic evaluation of prostate cancer.  
  Alexander Joan et al. Cancer research 2017 Nov